SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Abou Diane)
 

Sökning: WFRF:(Abou Diane) > Beyond Average : a-...

Beyond Average : a-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer

Benabdallah, Nadia (författare)
Washington University in St. Louis
Lu, Peng (författare)
Washington University in St. Louis
Abou, Diane S. (författare)
Washington University in St. Louis
visa fler...
Zhang, Hanwen (författare)
Washington University in St. Louis
Ulmert, David (författare)
Lund University,Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Strålterapi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Radiation therapy,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,University of California, Los Angeles
Hobbs, Robert F. (författare)
Johns Hopkins University
Gay, Hiram A. (författare)
Washington University in St. Louis
Simons, Brian W. (författare)
Baylor University
Saeed, Muhammad A. (författare)
Washington University in St. Louis
Rogers, Buck E. (författare)
Washington University in St. Louis
Jha, Abhinav K. (författare)
Washington University in St. Louis
Tai, Yuan Chuan (författare)
Malone, Christopher D. (författare)
Ippolito, Joseph E. (författare)
Michalski, Jeff (författare)
Washington University in St. Louis
Jennings, Jack W. (författare)
Baumann, Brian C. (författare)
Washington University in St. Louis
Pachynski, Russell K. (författare)
Washington University in St. Louis
Thorek, Daniel L.J. (författare)
Washington University School of Medicine,Washington University in St. Louis
visa färre...
Washington University in St Louis LUCC: Lunds universitets cancercentrum (creator_code:org_t)
2024
2024
Engelska 7 s.
Ingår i: Journal of Nuclear Medicine. - 0161-5505. ; 65:2, s. 245-251
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • a-particle emitters are emerging as a potent modality for disseminated cancer therapy because of their high linear energy transfer and localized absorbed dose profile. Despite great interest and pharmaceutical development, there is scant information on the distribution of these agents at the scale of the a-particle pathlength. We sought to determine the distribution of clinically approved [223Ra]RaCl2 in bone metastatic castration-resistant prostate cancer at this resolution, for the first time to our knowledge, to inform activity distribution and dose at the near-cell scale. Methods: Biopsy specimens and blood were collected from 7 patients 24 h after administration. 223Ra activity in each sample was recorded, and the microstructure of biopsy specimens was analyzed by micro-CT. Quantitative autoradiography and histopathology were segmented and registered with an automated procedure. Activity distributions by tissue compartment and dosimetry calculations based on the MIRD formalism were performed. Results: We revealed the activity distribution differences across and within patient samples at the macro- and microscopic scales. Microdistribution analysis confirmed localized high-activity regions in a background of low-activity tissue. We evaluated heterogeneous a-particle emission distribution concentrated at bone–tissue interfaces and calculated spatially nonuniform absorbed-dose profiles. Conclusion: Primary patient data of radiopharmaceutical therapy distribution at the small scale revealed that 223Ra uptake is nonuniform. Dose estimates present both opportunities and challenges to enhance patient outcomes and are a first step toward personalized treatment approaches and improved understanding of a-particle radiopharmaceutical therapies.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)

Nyckelord

Ra
a-particle
autoradiography
biopsy
dosimetry

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy